Background: The clinical significance of white matter hyperintensity (WMH) on brain magnetic resonance image (MRI) in Parkinson’s disease (PD) patients was not sufficiently understood. Little is known about WMH in PD patients in sub Saharan Africa (SSA). The objectives of this study were to determine white matter hyperintensity and associated factors in Ethiopian PD patients.Method: A cross-sectional observational study was conducted in 42 PD patients with WMH and 42 PD patients with normal MRI in Addis Ababa, Ethiopia. Both descriptive and analytical statistics were used to analyze the data. Results: Total of 84 patients with PD was included in the analysis. The overall mean age was 61.5 (11.6) years. Young onset PD (≤ 50 years) accounted 16.7%. Males accounted 67.9%. Tremor dominant PD accounted 88.1%. Forgetfulness and hallucination was reported by 8.3% and 13.1% respectively. The median serum vitamin D and the mean hemoglobin level was 14.9 (8.3 – 20.2) ng/mL and 14.8 (13.8) g/L respectively. Hypovitaminosis D was observed in 40.5% of PD patients; similarly, anemia was observed in 27.4%. Negative correlation was observed between participant’s age and their respective hemoglobin level. The prevalence of hypertension, diabetes, and dyslipidemia was 29.8%, 13.1%, and 20.2% respectively. No association was observed between white matter hyperintensity and young onset PD, hypovitaminosis D, hypertension, and diabetes. Age and dyslipidemia were found to be independent predictor of white matter hyperintensity, when adjusted for the covariates.Conclusion: The present study indicates advanced age and dyslipidemia were associated with increased risk of having white matter hyperintensity on brain MRI of Ethiopian PD patients compared to those patients with normal MRI. Even though non-significant, the trend of vascular risk factors was in line with WMH.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.